Lyso‐globotriaosylsphingosine (lyso‐Gb<sub>3</sub>) levels in neonates and adults with the Fabry disease later‐onset <i>GLA</i> IVS4+919G>A mutation
Yin‐Hsiu Chien(National Taiwan University Hospital), Wuh‐Liang Hwu(MRC Epidemiology Unit), Hermann Mascher(Institut für Schlaganfall- und Demenzforschung), Christina Hung(Boston Children's Hospital), Olaf A. Bodamer(Broad Institute), Shu‐Chuan Chiang(National Taiwan University Hospital)
Cited by 23
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Biparental Inheritance of Mitochondrial DNA in Humans
|Proceedings of the National Academy of Sciences|2018|451
PSORS2 Is Due to Mutations in CARD14
|The American Journal of Human Genetics|2012|414